Document is current
Any future updates will be listed below
-
Authors
Milgrim, Frederick https://orcid.org/0000-0003-1093-503X
Riscinti, Matthew
Goldsmith, Andrew
Nagdev, Arun
Brown, Joseph
- License Information
-
More Information
Article History
Received: 10 January 2025
Accepted: 11 February 2025
First Online: 3 March 2025
Declarations
:
: Matthew Riscinti previously received grants from the U.S. Department of Defense and previously consulted for Exo Inc. and Butterfly Network. Andrew Goldsmith is the Medical Director of Ultrasight. Arun Nagdev is VP of Clinical for Exo Inc.
: As this piece represents a consensus guideline, patient approval was not obtained.
: Informed consent was not obtained.
: Not applicable.
